Literature DB >> 15044836

The HPV-16 E5 protein inhibits TRAIL- and FasL-mediated apoptosis in human keratinocyte raft cultures.

Kirsten Kabsch1, Nina Mossadegh, Annette Kohl, Gerda Komposch, Johannes Schenkel, Angel Alonso, Pascal Tomakidi.   

Abstract

By using raft cultures of the polyclonal HaCaT cell lines stably transfected either with E5 (HaCaT/E5) or the empty vector (HaCaT/pMSG) as reference, we investigated the effect of the human papillomavirus type 16 (HPV-16) E5 protein on apoptosis. In comparison to conventional monolayer cultures this model system allows analysis of apoptosis under more tissue-like conditions by mimicking the stratified organization of a normal surface epithelium. Apoptosis was triggered either by FasL or TRAIL. Execution of the death program was checked at early and late stages by monitoring procaspase-3 cleavage and DNA fragmentation, respectively. Rafts of E5-expressing keratinocytes were completely protected from apoptosis and showed a background of apoptotic cells as low as the untreated cultures. In contrast, the HaCaT/pMSG cultures revealed a dramatic increase in apoptotic cells upon ligand treatment throughout the epithelial compartment. We conclude that the presence of the HPV-16 E5 protein in our tissue-like model prevents FasL- or TRAIL-mediated apoptosis. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15044836     DOI: 10.1159/000076642

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  18 in total

1.  A role for HPV16 E5 in cervical carcinogenesis.

Authors:  John P Maufort; Anny Shai; Henry C Pitot; Paul F Lambert
Journal:  Cancer Res       Date:  2010-03-23       Impact factor: 12.701

2.  Human Papillomavirus 11 Early Protein E6 Activates Autophagy by Repressing AKT/mTOR and Erk/mTOR.

Authors:  Boya Zhang; Yinjing Song; Siyuan Sun; Rui Han; Chunting Hua; Stijn van der Veen; Hao Cheng
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

3.  Quantitative measurement of human papillomavirus type 16 e5 oncoprotein levels in epithelial cell lines by mass spectrometry.

Authors:  Ziad Sahab; Sawali R Sudarshan; Xuefeng Liu; YiYu Zhang; Alexander Kirilyuk; Christopher M Kamonjoh; Vera Simic; Yuhai Dai; Stephen W Byers; John Doorbar; Frank A Suprynowicz; Richard Schlegel
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

4.  Bap31 is a novel target of the human papillomavirus E5 protein.

Authors:  Jennifer A Regan; Laimonis A Laimins
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

Review 5.  The E5 proteins.

Authors:  Daniel DiMaio; Lisa M Petti
Journal:  Virology       Date:  2013-05-31       Impact factor: 3.616

Review 6.  The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation.

Authors:  James A Scarth; Molly R Patterson; Ethan L Morgan; Andrew Macdonald
Journal:  J Gen Virol       Date:  2021-01-11       Impact factor: 3.891

Review 7.  Papillomavirus E5: the smallest oncoprotein with many functions.

Authors:  Aldo Venuti; Francesca Paolini; Lubna Nasir; Annunziata Corteggio; Sante Roperto; Maria S Campo; Giuseppe Borzacchiello
Journal:  Mol Cancer       Date:  2011-11-11       Impact factor: 27.401

Review 8.  Protein-Protein Interactions of Viroporins in Coronaviruses and Paramyxoviruses: New Targets for Antivirals?

Authors:  Jaume Torres; Wahyu Surya; Yan Li; Ding Xiang Liu
Journal:  Viruses       Date:  2015-06-04       Impact factor: 5.048

9.  Nip the HPV encoded evil in the cancer bud: HPV reshapes TRAILs and signaling landscapes.

Authors:  Talha Abdul Halim; Ammad Ahmad Farooqi; Farrukh Zaman
Journal:  Cancer Cell Int       Date:  2013-06-17       Impact factor: 5.722

10.  The invisible enemy - how human papillomaviruses avoid recognition and clearance by the host immune system.

Authors:  Agnieszka K Grabowska; Angelika B Riemer
Journal:  Open Virol J       Date:  2012-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.